H eat shock protein 70 (Hsp70) is a member of a ubiquitously expressed family of molecular chaperones that are involved in protein homeostasis. In its role as a mediator of protein fate, this chaperone has been linked to multiple tasks, including roles in de novo protein folding, subcellular trafficking, protein disaggregation, proteasome-mediated degradation, and autophagy (1) (2) (3) (4) (5) (6) . In addition, Hsp70 has been linked to numerous diseases, especially cancer and disorders of protein folding (7) . Thus, there is interest in better understanding the biology of Hsp70 in order to test its potential as a therapeutic target (8) .
To accomplish its various chaperone functions, Hsp70 physically interacts with the exposed hydrophobic residues of polypeptides via its C-terminal substratebinding domain (SBD). Hydrolysis of ATP in the adjacent, N-terminal nucleotide-binding domain (NBD) propagates an allosteric change to the SBD, resulting in an approximately 10-fold enhancement in substrate affinity (9) (10) (11) (12) . These findings suggest an important role for the nucleotide state in controlling the interactions of Hsp70 with misfolded substrates. Consistent with the proposed importance of nucleotide turnover, a family of essential co-chaperones, the Hsp40s, is known to tightly regulate the ATPase rate of Hsp70. These co-chaperones are defined by the presence of a conserved, 60 amino acid J-domain. Interaction of the J-domain with the NBD of a Hsp70 stimulates its ATP hydrolysis and favors tight association with bound substrates. For example, the J-domain containing co-chaperone, DnaJ, stimulates the nucleotide hydrolysis rate of the well-characterized pro-*Corresponding author, gestwick@umich.edu.
karyotic Hsp70, DnaK, by at least 5-fold and favors DnaK-substrate interactions (13) (14) (15) (16) . The residues in the NBD that are important for this co-chaperone partnership are ϳ15-20 Å removed from the nucleotidebinding cleft, suggesting that the J-domain controls ATPase activity through allostery (17) (18) (19) (20) . Regulation by J-domain-containing Hsp40s appears to be critical, because loss-of-function mutations compromise viability in vivo (21, 22) . Moreover, overexpression of Hsp40s is sometimes sufficient to impact disease in certain models, further suggesting an important physiological role for the Hsp70-Hsp40 complex (23, 24) . Finally, most organisms express multiple J-domain proteins (e.g., more than 40 examples are known in humans and approximately 22 in Saccharomyces cerevisiae), which is an observation that has led to the hypothesis that some co-chaperones play specific cellular roles, such as during a stress response (22, (25) (26) (27) . Despite these important advances and interesting observations, one of the major questions in chaperone biology is how Hsp70 and its Hsp40 co-chaperones cooperate to shape specific cellular responses.
To understand chaperone regulation in greater detail, we have designed chemical screens against the multiprotein complex (i.e., Hsp70 and a representative J-domain co-chaperone) to uncover probes that might be used to control Hsp70 within the context of the intact chaperone machine (7, (28) (29) (30) (31) . During these studies, we found that certain dihydropyrimidines impact the ATPase activity of Hsp70, but only in the presence of J-domain proteins (32) . For example, the dihydropyrimidine MAL3-101 inhibits ATPase activity, but only when added together with the J-domain of T-antigen (32) . These findings suggest an interesting but mysterious interplay between this class of compounds and the Hsp40 co-chaperones. It appears to be worthwhile to understand this mechanism, because dihydropyrimidines have interesting biological activity in cell-based and animal models of tauopathy (33) and in anticancer studies (31, 34, 35) . Here, we present the surprising finding that a model dihydropyrimidine, 115-7c, binds to a region adjacent to the surface required for J-domain stimulation and that it utilizes a parallel allosteric conduit to synergistically regulate Hsp70-dependent ATP turnover. These observations provide insight into the regulation of the chaperone complex and illustrate how chemical probes with interesting and unexpected mechanisms can be uncovered in screens against multiprotein targets.
RESULTS AND DISCUSSION
Identification of a Compound That Stimulates the in Vitro Functions of DnaK. Using ATPase and protein folding activities as end points, we previously identified dihydropyrimidines that either stimulate or inhibit chaperone functions in vitro (29, 30) . From these studies, structureϪactivity analysis led to the synthesis of 115-7c (Figure 1, panel A) , which is a compound that www.acschemicalbiology.org stimulates the ATPase activity of full-length Escherichia coli Hsp70, DnaK (DnaK FL ), by ϳ50% at 100 M ( Figure 1, panel B) . Because the binding of peptide substrates to the SBD of DnaK is known to stimulate ATP hydrolysis (29), our first hypothesis was that 115-7c might also bind in this region. To test this model, we determined the activity of 115-7c against a truncated mutant composed of only the NBD (DnaK NBD ). These experiments revealed that 115-7c retained full activity against DnaK NBD (hydrolysis rate increased ϳ2-fold at 100 M), suggesting that the SBD is dispensable.
One of the major functions of Hsp70 is to assist in protein folding. Accordingly, the ATP-dependent, chaperone-mediated refolding of chemically denatured firefly luciferase is a common assay for studying this system in vitro (30, 36, 37) . To explore the effects of 115-7c in this model, we denatured firefly luciferase with guanidinium hydrochloride and then diluted this substrate in the presence of the prokaryotic Hsp70 system, composed of DnaK, DnaJ, and the nucleotide exchange factor, GrpE. In this platform, 115-7c stimulated refolding activity by ϳ2-fold at 1 M (Figure 1, panel C) . Together, these results indicate that the dihydropyrimidine, 115-7c, stimulates two major functions of a Hsp70 chaperone system in vitro, ATPase rate and protein folding.
Compound 115-7c Is an Artificial Co-chaperone in Yeast. Stimulation of Hsp70s ATPase and folding activities is a function typically associated with J-domain cochaperones; thus, we hypothesized that 115-7c might act as an artificial co-chaperone in cells. To explore this idea, we turned to a S. cerevisiae model in which a role for J-domains has been clearly documented (22) . Ydj1 is one of the DnaJ orthologs in budding yeast and the growth of a ydj1⌬ mutant is severely compromised at elevated temperature (21, 22, 38) . Based on the in vitro studies, we hypothesized that 115-7c might partially compensate for the loss of YDJ1. To investigate this possibility, we treated ydj1⌬ cells with 115-7c by incorporating this compound into the solid growth media. As expected, the mock treated ydj1⌬ cells grew slowly at 30°C and failed to thrive at 34°C (Figure 2, panel A) . Application of 115-7c (100 M), however, greatly enhanced growth at the elevated temperature ( Figure 2 , panel A). As an independent test, we also treated ydj1⌬ cells with calcofluor white (Figure 2, panel B) . Calcofluor white is known to impair cell wall biogenesis and it preferentially decreases the viability of ydj1⌬ mutants (39) . Treatment with 115-7c (100 M) partially suppressed this phenotype (Figure 2, panel B) , mirroring the results of the thermal stress experiments. We found these results particularly striking because we are unaware of similar examples in which a gene deletion can be recovered by a small, synthetic mimetic. However, it is worth noting that 115-7c only partially compensated for the loss of Ydj1p and relatively high quantities of the small molecule were required.
115-7c
Binds to the IIA Subdomain of DnaK. To better understand the molecular mechanisms by which 115-7c stimulates ATPase activity and suppresses ydj1⌬ phenotypes, we performed nuclear magnetic resonance (NMR) experiments on DnaK NBD . In these experiments, 115-7c and DnaJ Appear To Access Parallel Allosteric Mechanisms. Intriguingly, the IA and IIA regions of the NBD have also been implicated in the activity of J-domains, and multiple point mutants in these regions have been found to block stimulation by these cochaperones (17, 18, 42, 43) . To probe whether there might be overlap between these J-domain-responsive residues and those that we found in the NMR experiment with 115-7c, we first highlighted the key amino acids on the structure of DnaK NBD (Figure 4, panel A) . This analysis suggested that the artificial and natural cochaperones occupy only partially overlapping sites. Thus, we hypothesized that mutations in select residues might block allosteric activation by either the J-domain co-chaperone or 115-7c. To test this model, we made point mutations in three residues (E171S, E217A, and Y193A) of DnaK FL and measured the responsiveness of the corresponding mutant proteins. The E171S mutation was chosen because it was previously reported to be required for stimulation by J-domains (17) , and consistent with that idea, we confirmed that the ATPase activity of DnaK Fl (E171S) was nonresponsive to DnaJ addition (Figure 4, panel B) . In contrast, 115-7c retained full activity against this mutant. Thus, these results showed that activation of ATP hydrolysis by the chemical probe and the Hsp40 were separable, suggesting incomplete overlap between the allosteric pathways of these stimulatory factors. In support of this model, we found that DnaK FL (Y193A) was responsive to DnaJ but not 115-7c (Figure 4, panel B) . Finally, we explored the influence of a residue that was predicted to be important for both J-domains and 115-7c. This mutant, DnaK FL (E217A), was stimulated by the small molecule but not by DnaJ, further suggesting that the two partners access distinct pathways ( Figure 4, panel B) . Importantly, although some of these mutations altered the intrinsic hydrolysis rates (17), they did not impact global structure, as measured by circular dichroism (CD; Supplementary Figure 2) . Together, the results of these mutagenesis studies suggest that there are at least two allosteric pathways in DnaK NBD and that the artificial and native co-chaperones access parallel conduits. As discussed in more detail below, this activity is likely a byproduct of the screening approach that produced 115-7c; successful compounds were those that stimulated the DnaK-DnaJ complex (29) .
Compound 115-7c Binds Better to the DnaKDnaJ Complex than to DnaK Alone. Because the binding sites of the two co-chaperones were only partially overlapping, we wanted to understand whether 115-7c and DnaJ could compete for binding to DnaK. Toward this goal, we first measured 115-7c binding by isothermal calorimetry (ITC) and found that it binds weakly to both DnaK FL Figure 5 , panel A and Supplementary Figure 3) . Next, we attempted to block interactions with 115-7c using saturating levels of DnaJ. Surprisingly, we found that 115-7c bound ca. 2-fold better to the DnaKDnaJ complex than the isolated chaperone (K D Ϸ 113 Ϯ 29 M; Figure 5 , panel A). Because 115-7c had a weak (Ͼ1 mM) affinity DnaJ (Supplementary Figure 3B) , these results suggest that 115-7c has a more favorable binding site on the composite DnaK-DnaJ complex than on DnaK alone.
Converting 115-7c into an Inhibitor by Preventing Synergy with the J-domain. On the basis of these results, we envisioned a simple ternary model in which both 115-7c and DnaJ bind DnaK in the cleft between the IIA and IA subdomains ( Figure 5, panel B) . Because the residues important for these functions are in relatively close proximity, we next explored whether adding bulk to the small molecule could create steric clashes. In these studies, we focused on the dicholorobenzyl moiety of 115-7c, because this region was predicted to be relatively solvent exposed and pointed toward the J-domain responsive residues in the docked model (see Figure 3, panel C) . This analysis led to the selection of 116-9e (29) , which is similar to 115-7c except that the dichlorobenzyl functionality has been replaced with a bulkier diphenyl group. In the ATPase assay, 116-9e had little effect on the DnaK-GrpE combination, but this agent inhibited the DnaK-DnaJ complex by ϳ80%, suggesting that it selectively interfered with J-domain-mediated activation of DnaK's ATPase activity www.acschemicalbiology.org ( Figure 5, panel C) . To further explore this relationship, we titrated DnaJ into DnaK NBD in the presence of either 115-7c or 116-9e and measured ATPase activity. In these experiments, we found that 115-7c reduced the amount of DnaJ required to stimulate DnaK NBD by 1.5-fold ( Figure 5, panel D) . Conversely, 116-9e strongly suppressed J-domain-mediated stimulation of ATPase activity ( Figure 5, panel D) . Together, these results suggest that 115-7c and 116-9e tune chaperone activity in the context of the DnaK-DnaJ complex. In further support of this mechanism, 116-9e suppressed DnaK-mediated luciferase folding (Supplementary Figure 4C) , which is a process that requires a Hsp40 (30) . Together, these results suggest a mechanism in which 115-7c uses an allosteric pathway at a protein-protein interface to stimulate ATPase activity, whereas 116-9e might block DnaJ-DnaK interactions.
Compound 115-7c Phenocopies Hsp70 Overexpression in a Yeast Model of Polyglutamine Disease. On the basis of the findings that the artificial and natural co-chaperone can sometimes work together, we expected that treatment with 115-7c might stimulate Hsp70 in cells, even those that express a full complement of native co-chaperones. To test this hy- pothesis, we employed a yeast-based, polyglutamine (polyQ) aggregation model. In this system, expression of an expanded polyQ domain fused to GFP (e.g., Q72-and Q103-GFP) results in fluorescent puncta, while the shorter Q25-GFP and Q47-GFP proteins are less prone to aggregation and therefore remain more diffusely distributed ( Figure 6, panel B) (44) . We chose this system because overexpression of human Hsp70 has been shown to reduce the tendency of Q103-GFP to form single puncta (44) . Thus, we tested whether the stimulatory molecule 115-7c might also produce a similar result. In our hands, overexpression of either SSA1 (a yeast Hsp70 ortholog) or YDJ1 (a yeast Hsp40) altered the fluorescence patterns in Q72-or Q103-expressing cells, resulting in multiple, small puncta with correspondingly higher cytoplasmic fluorescence ( Figure 6, panel A) . Strikingly, treatment with 115-7c also produced smaller puncta in Q72-and Q103-expressing cells ( Figure 6,  panel B) . Specifically, cells treated with 115-7c had an average of 5Ϫ8 small puncta per cell, whereas mock treated cells typically had 1-2 large puncta ( Figure 6 , panel C). Importantly, this compound had no effect on Q25-or Q47-expressing cells, suggesting that its effects were specific to aggregation-prone polyQ ( Figure 6 ). Because the potency of 115-7c is modest (ϳ100 M), we were concerned that this activity might arise from detergent-like or other nonspecific effects. To test this idea, we used SW19, a compound that resembles 115-7c but lacks any activity in the ATPase or luciferaserefolding assay (Supplementary Figure 4A-C) . This control compound failed to impact aggregation patterns in cells expressing polyQs (Supplementary Figure 4D,E) . Moreover, the inhibitor 116-9e was unable to significantly alter aggregation outcomes in polyQ-expressing cells (Supplementary Figure 4D,E) . These results suggest that the stimulatory activity of 115-7c is required for its ability to impact aggregation patterns. In further support of this model, immobilized 115-7c bound to yeast cytosolic Hsp70s (Ssa1p and Ssa2p) in lysates (Supplementary Figure 5A ). These results suggest that 115-7c binds to Hsp70 in yeast. However, another possibility is that this molecule stimulates a stress response, because this pathway is also thought to repress polyQ aggregation. To test this idea, we employed LacZ reporters of either the heat shock response or the unfolded protein response. In these systems, 115-7c failed to induce a stress response by either measurement, whereas known positive controls and elevated temperatures both activated the reporters (Supplementary Figure 5B) . Finally, 115-7c was relatively stable during the course of these experiments, as measured by LC-MS (Supplementary Figure 6) . Together, these studies suggest that the dihydropyrimidine acts through Hsp70s ATPase activity to influence polyQ aggregation.
Conclusions. Dihydropyrimidines, such as 115-7c, have been previously identified as pharmacological modulators of Hsp70, and these molecules were found to display an interesting but unexplained dependence on J-domains for their function (32) . To explore the mechanistic origins of this effect, we used a combination of biochemical assays, NMR, and computational modeling to reveal that 115-7c binds to the IIA subdomain and accesses a previously unidentified allosteric pathway. Remarkably, the compound was able to partially suppress ydj1⌬ phenotypes in yeast. This stimulatory activity was not competitive with a J-domain cochaperone, and in fact, these factors appeared to work together to stimulate nucleotide hydrolysis. On the basis of these data, we converted 115-7c into a contextdependent inhibitor, 116-9e, by appending steric bulk. Interestingly, an inhibitor that was previously identified as being sensitive to J-domains, MAL3-101, also has a diphenyl substitution at the same position as 116-9e (32) . These results might help clarify how compounds like 115-7c might be reassigned as either activators or inhibitors depending on both their chemical substitution patterns and the presence of J-domains.
Hsp70 is highly conserved among both prokaryotes and eukaryotes, with approximately 50% identity and 70% similarity between E. coli DnaK and other eukaryotic Hsp70s, such as human Hsp72 and yeast Ssa1. Moreover, the binding site for 115-7c, as determined by NMR, is well conserved, with many of the key residues maintained throughout evolution (Supplementary Figure 7) . Thus, we hypothesize that 115-7c might act on other Hsp70 isoforms. In support of this idea, 115-7c has activity in yeast (Figure 6 ). Moreover, it also stimulates human cytoplasmic Hsp70 (33) and related compounds have activity against Ssa1 (32) .
An interesting and unexpected aspect of this study is that the small molecules appear to operate at a protein-protein interface to either stimulate or disrupt Hsp70-Hsp40 interactions. A growing number of studies have reported inhibitors of protein-protein interactions (45, 46) . In those reports, the molecules typically bind to one protein partner and either directly (47) or allosterically (48, 49) block formation of the proteinprotein complex. Some recent examples have even demonstrated that stimulators of protein function can be identified (50, 51) , but these compounds are not thought to act at natural protein-protein interfaces. Our findings provide evidence that inhibitory activities at protein-protein contacts are not predestined (52) . Together, these findings suggest exciting new avenues for regulating the assembly, disassembly and function of multiprotein complexes (53) .
We hypothesize that the unusual mechanism of 115-7c may be an unintended byproduct of the highthroughput screening approach. Specifically, the screen that yielded this compound targeted the combination of DnaK and DnaJ (29) . As mentioned above, the J-domain does not have intrinsic ATPase activity but only stimulates the activity of the core Hsp70. Thus, we suspect that screens of the reconstituted complex might have favored identification of a molecule with the observed mechanistic properties at the Hsp70-Hsp40 interface. It is interesting to speculate that additional stimulators and inhibitors might be uncovered using a similar strategy.
More broadly, these findings also establish 115-7c and its derivatives as novel probes to explore Hsp70s important roles in protein homeostasis. Genetic manipulation of Hsp70 is typically not well tolerated, and thus new chemical probes that acutely and transiently disrupt its functions are needed (7, 8) . By analogy, inhibitors of Hsp90 have been instrumental in understanding that protein (54) . Moreover, a growing number of studies have implicated Hsp70 and its cochaperones in disease pathways, such as cancer and neurodegeneration (7, 55, 56) . In fact, 115-7c has recently been used in cell-based and animal models of tau-based neurodegeneration to reveal that Hsp70 activity is critical for controlling tau stability and quality control (33) . In other experiments, this compound was found to influence processing of Akt, another Hsp70 substrate (34), and similar compounds have been found to have anticancer activity (31, 35) . In the present study, we found that 115-7c disrupts polyQ aggregation, providing another potential avenue toward pharmacologic intervention. The mechanistic insights provided by this work help clarify why dihydropyrimidines have activity in these disease models, and they suggest an important role for the Hsp70-Hsp40 complex in pathology.
METHODS
Reagents and General Methods. E. coli DnaK FL (residues 1-605), DnaK NBD (residues 1-388), DnaJ and GrpE were expressed in BL21/DE3 and purified as previously described (29) . Dihydropyrimidines 115-7c and 116-9e were synthesized by microwave-accelerated Biginelli reactions as described (57) . Both the ATPase assays and luciferase refolding assays were also performed as described (29, 30) . The concentrations of DnaK DnaJ and GrpE in the ATPase assay were 0.6, 1.0, and 0.9 M, respectively. The concentrations of DnaK DnaJ and GrpE in the luciferase assay were 0.2, 0.05, and 0.02 M, respectively.
Yeast Growth Experiments. Wild-type yeast of the W303 background (MATa, leu2-3,112 his3-11 trp1-1 ura3-1 can1-100 ade2-1) and a ydj1⌬ strain (DYJ1) (MATa ura3-52 lys2-801 ade2-101 trp1-⌬63 his3-⌬200 leu2-⌬1 ydj1::TRP1) were used. These cells were grown in rich media (YPD) at 30°C overnight, followed by dilution to OD 600 of 0.5. For the experiments performed at elevated temperature, cells were spotted in 5-fold dilutions on YPD agar plates. These plates were pretreated with compound (100 M) or DMSO alone (0.5%). The plates were grown at 30 or 34°C for 4 days. In the calcofluor white experiments, the YPD plates were pretreated with this compound to a final concentration of 20 g mL
Ϫ1
, alone or in combination with 115-7c (100 M), followed by incubation at 30°C for 4 days. NMR Spectroscopy.
15
N-Labeled DnaK FL and DnaK NBD were expressed in standard minimal medium containing 15 NH 4 Cl as the sole nitrogen source, using T7-based expression vectors. Following purification, proteins were concentrated to approximately 0.5 mM, exchanged into NMR buffer (25 mM Tris, 10 mM MgCl 2 , 5 mM KCl, 10% 2 H 2 O, 0.01% sodium azide, pH 7.1), and stored at Ϫ80°C until use. Prior to NMR analysis, DnaK 2-388 samples were thawed and supplemented with 5 mM nucleotide (e.g., ATP or ADP) and 10 mM potassium phosphate. Samples of DnaK FL were additionally supplemented with 2.5 mM of a high affinity peptide (NRLLLTG) (41) . After collecting reference spectra, 115-7c was added to a final concentration of 1 mM from a 100 mM stock in DMSO. The chemical shifts were in fast exchange on the NMR time scale and were saturable at a 1:1 ratio of compound and DnaK. Control experiments showed that DMSO alone had no detectable effects on the spectrum of DnaK NBD at concentrations up to 1% and minimal effects on the spectra of DnaK FL at the same concentration. 2D HSQC-TROSY NMR spectra were collected at 30°C on a cryogenic probe-equipped Varian Inova 800 MHz spectrometer, with data collection times of approximately 2 h per spectrum. NMR data were processed using NMRPipe (58) and analyzed with Sparky. Combined (62) . Briefly, this procedure involved four core steps: (1) generating ligand poses into the defined binding site by softened-potential docking, (2) refining residue side chains near each ligand pose from the first step, (3) redocking ligand into the optimized induced-fit structure, and (4) scoring the poses by docking energy (GlideScore) and receptor energetic terms (Prime energy). The ligand and protein were prepared in Maestro (2007). IFD was initiated with a constrained minimization of the receptor. The prime loop prediction function of IFD was used to generate a maximum of 5 alternative loop (D208-T215) conformations for Glide docking. Side-chain refinement was performed to residues within 5.0 Å of the defined loop segment. Predicted loop structures with energy 30 kcal/mol above the lowest-energy structure were rejected. In the first stage of docking, Glide docked ligand into the rigid receptor with a softened van der Waals potential. The grid box was centered at residue E206 (based on the NMR results), and the box size was determined automatically. Ten top scoring ligand poses were retained, and for each initial docking pose, Prime performed sidechain refinement to residues that were within 5.0 Å of the ligand, allowing the side chains to adopt optimal conformation to interact with the ligand. Glide then redocked the ligand into the induced-fit receptor with standard parameters, and the final ligand poses were scored using a combination of Glide SP score and Prime energy. Ligand poses with ligand-receptor interactions in agreement with the observed NMR chemical shifts were accepted.
Isothermal Calorimetry. Isothermal calorimetric titrations were performed with a VP-ITC microcalorimeter (MicroCal) at 37°C. Titration experiments were performed in 25 mM PBS (pH 7.4), 5 mM MgCl 2 , 150 mM KCl, 5% DMSO. DnaK FL (60 M), DnaK NBD (60 M), or DnaJ FL (1 mM) were extensively dialyzed and then introduced into the calorimetric cell (cell volume ϭ 1.43 mL). Protein samples were then titrated with 500 M 115-7c in 15 L steps (see Supplementary Figure 3 for representative injections). Injections were performed at 2 L s
Ϫ1
. Data were analyzed using Microcal Origin (v2.9) assuming independent binding sites to yield enthalpy, stoichiometry of binding, and association constants.
Yeast Polyglutamine Aggregation Experiments. Integrated plasmids (p416 vector) expressing huntingtin exon I fragments with 25 and 103 glutamines flanked by an N-terminal Flag tag and a C-terminal green fluorescent protein (GFP) (44) were transformed into a yeast strain of the W303 background. Alternatively, related polyQ constructs were co-expressed in strains harboring galactose-inducible SSA1 (Ssa11) or YDJ1 (Ydj11) (Invitrogen). Yeast cultures were grown to midlog phase in selective media (SC-His) for microscopy. If appropriate, the cells were induced by growing in SC-His containing 2% raffinose, followed by centrifugation (2000 rpm, 5 min) and resuspension to an OD 600 of 0.3 in SC-His media containing 2% galactose. The cultures were grown at 30°C in presence of 115-7c (100 M), 116-9e (100 M), or an equivalent volume of DMSO (1%). Fluorescence microscopy was performed using a Nikon Eclipse 80i microscope, where the cells were imaged 24 h after induction at 100x magnification. The number of puncta found in cells from www.acschemicalbiology.org 3-10 random fields was used for quantification, and error represents the variance between fields. Nonfluorescent or weakly fluorescent cells were uniformly excluded.
